Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials

Documenti analoghi

• Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes
  di: Ulrike Hövelmann, et al.
  Pubblicazione: (2024)
• Biosimilar insulins: Narrative review of the regulatory framework and registration studies
  di: Tim Heise, et al.
  Pubblicazione: (2025)
• Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double‐Blind Phase II Trial
  di: Ping Jin, et al.
  Pubblicazione: (2026)
• Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability
  di: Gian Paolo Fadini, et al.
  Pubblicazione: (2026)
• Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach
  di: Anders Strathe, et al.
  Pubblicazione: (2026)